Matches in Wikidata for { <http://www.wikidata.org/entity/Q65389017> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q65389017 description "clinical trial" @default.
- Q65389017 description "ensayu clínicu" @default.
- Q65389017 description "klinisch onderzoek" @default.
- Q65389017 description "клінічне випробування" @default.
- Q65389017 name "Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer" @default.
- Q65389017 name "Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer" @default.
- Q65389017 type Item @default.
- Q65389017 label "Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer" @default.
- Q65389017 label "Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer" @default.
- Q65389017 prefLabel "Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer" @default.
- Q65389017 prefLabel "Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer" @default.
- Q65389017 P1132 Q65389017-86CEDF5C-B319-4333-888B-DD0047AB7869 @default.
- Q65389017 P1476 Q65389017-B0A00F56-7644-4AD7-A4D3-FB2585EF2532 @default.
- Q65389017 P17 Q65389017-683F39EB-7D5A-4C65-8B56-E4A0E820CADB @default.
- Q65389017 P1813 Q65389017-844BE252-AC9D-4022-B16D-087F722CCF8E @default.
- Q65389017 P2899 Q65389017-4D6CFA8D-6838-4959-9DCB-B68A8AA9B5F2 @default.
- Q65389017 P3098 Q65389017-93E686C0-C18C-42D4-838B-6C13ABDB57FF @default.
- Q65389017 P31 Q65389017-EB0580AC-36EB-42A1-9E10-DFF9C0392F2F @default.
- Q65389017 P580 Q65389017-7AD97865-9990-43B8-8F91-1FD87CF209F4 @default.
- Q65389017 P582 Q65389017-F9ECA02A-B955-4189-8DD7-DD1F3B27C4BA @default.
- Q65389017 P6099 Q65389017-991F348B-3E9C-49A4-BE85-BDC8240AC656 @default.
- Q65389017 P6153 Q65389017-6789F6BB-4928-417E-BF27-244876410D78 @default.
- Q65389017 P8363 Q65389017-36EDB520-C4D6-48DF-B929-292D96EF917B @default.
- Q65389017 P859 Q65389017-646C773E-84CF-43EB-B792-F932A023513F @default.
- Q65389017 P1132 "+168" @default.
- Q65389017 P1476 "Neoadjuvant Therapy for Postmenopausal Women With ER and/or PgR Positive Breast Cancer. A Randomized Open Phase II Trial Evaluating the Efficacy of a 6 Months Preoperative Treatment With Letrozole (2.5 mg/Day) With or Without Zoledronic Acid (4 mg Every 4 Weeks)" @default.
- Q65389017 P17 Q183 @default.
- Q65389017 P1813 "FEMZONE" @default.
- Q65389017 P2899 "+18" @default.
- Q65389017 P3098 "NCT00375752" @default.
- Q65389017 P31 Q30612 @default.
- Q65389017 P580 "2006-06-01T00:00:00Z" @default.
- Q65389017 P582 "2010-12-16T00:00:00Z" @default.
- Q65389017 P6099 Q42825046 @default.
- Q65389017 P6153 Q507154 @default.
- Q65389017 P8363 Q78089383 @default.
- Q65389017 P859 Q507154 @default.